Cathy Handy Marshall, MD MPH

Writer of Handy Advice, Hopkins Genitourinary medical oncologist, host of Harrison’s Podclass, and now also a Baltimorean

[Cathy Handy Marshall, MD MPH @CathyHandy]

Our haiku about #prostatecancer and the #PCFRetreat24 with @PCFnews by @Freitas_PedroFS @SylvanBacaLab

What do you think?
😊 @DrRanaMcKay @EAntonarakis @MarkowskiGUOnc @DrChoueiri @soulehoward1 @AndreaMiyahira @mishabeltran @JoshLangMD

[Cathy Handy Marshall, MD MPH @CathyHandy]

Having a great time at #ASCO2023 with mentor @EAntonarakis presenting work on olaparib mono therapy in prostate cancer on behalf of

[Lustgarten Foundation @lustgartenfdn]

Congratulations to Lustgarten's Chief Medical Advisor @DrLizJaffee on the 2022 @AACI_Cancer Distinguished Scientist Award for her groundbreaking research in treating pancreatic cancer with immunotherapy. @hopkinskimmel #AACI2022

[Cathy Handy Marshall, MD MPH @CathyHandy]

results from pembro + olaparib in #mcrpc PSA response rate 15%; ORR 8.5%; treatment related grade 3-5 AE 48% and deaths due to AEs in 5.9%

https://t.co/SyK2wtOfve

[Cathy Handy Marshall, MD MPH @CathyHandy]

argument in favor of continuing to allow #telemedicine across state lines!

https://t.co/w88aQwCYFV

[Cathy Handy Marshall, MD MPH @CathyHandy]

#metastasis directed therapy in #ProstateCancer update by @matthewdeek and colleagues
https://t.co/TRyV1WibM7

[Cathy Handy Marshall, MD MPH @CathyHandy]

#cancer and #cardiovascular disease
https://t.co/mhO2xYYcay

[Cathy Handy Marshall, MD MPH @CathyHandy]

https://t.co/UgmeHmUqMF

[Cathy Handy Marshall, MD MPH @CathyHandy]

https://t.co/hPEV36NPbi

[Emmanuel Antonarakis @EAntonarakis]

Delighted to share our review article on CHIP in solid tumors. Congrats to @CathyHandy @LukaszPGondek https://t.co/bBEkySZsjO

[Cathy Handy Marshall, MD MPH @CathyHandy]

And a guide to bipolar androgen therapy...high dose testosterone + androgen deprivation therapy to treatment advanced prostate cancer.

https://t.co/ya5qLY3eFX

[Cathy Handy Marshall, MD MPH @CathyHandy]

interesting article here about way to identify people who might be able to avoid prostate biopsy and just go strait to surgery. very small study but raises some interesting questions...
https://t.co/7kM9MdNmeW

[Cathy Handy Marshall, MD MPH @CathyHandy]

❤️cardiovascular events and association with immune checkpoint inhibitors

https://t.co/HicwoRaHE5

[Johns Hopkins Medicine @HopkinsMedicine]

Following today’s Supreme Court decision to overturn Roe v. Wade, leaders from @johnshopkins and @hopkinsmedicine shared a message today affirming our commitment to following evidence-based best practices to the fullest extent of the law. https://t.co/HT5YMNVPHp

[Nima Sharifi @NimaSharifiMD]

Interesting @NEJM letter & hypothesis on AR blockade-induced #hypertension. There are data! Perhaps time to reshare our @Annals_Oncology paper on how AR blockade affects biochemical loss of 11BHSD2 which can explain HTN. @gulleyj1 @EricKleinMD @MM_Alyamani https://t.co/PMmYDSKhsF

[Cathy Handy Marshall, MD MPH @CathyHandy]

@ASCO guidelines on #exercise #diet and #weight management during #cancer treatment

https://t.co/6YgXzDhOwy

[Cathy Handy Marshall, MD MPH @CathyHandy]

Evidence supporting #healthy living for men at risk for #ProstateCancer

https://t.co/qAhL3mo16H

@loreleimucci

[Cathy Handy Marshall, MD MPH @CathyHandy]

Huge congrats 🎉🎉 to @MarkYarchoan on his recent promotion to Assoc Professor of #Oncoloy @hopkinskimmel
@Hopkins_HemOnc doing such great work on #livercancer and #Immunotherapy toxicity!!

[Cathy Handy Marshall, MD MPH @CathyHandy]

https://t.co/roBNGGgFyw

#ProstateCancer

[Cathy Handy Marshall, MD MPH @CathyHandy]

Results of the SPPORT trial #radonc - short term ADT + extending field of radiation in men with detectable #psa post prostatectomy improves outcomes #ProstateCancer

@_APollack @felixfangmd

https://t.co/NGiY0miFPS